Homozygous PIZZa1-antitrypsin (aAT) deficiency is the most common genetic cause of liver disease in children and of emphysema in adults. This deficiency is associated with a misfolding by functionally active aATZ molecule which is retained in the endoplasmic reticulum (ER) rather than secreted into the blood and body fluids. Lung injury is due to the decrease in a1AT molecules available in the lung to inhibit neutrophil elastases. Liver injury is due to the hepatotoxic effect of the misfolded a1AT molecule retained in the ER. The investigator has observed that a subgroup of PIZZ individuals may be more susceptible to liver injury by virtue of co-inherited variants in the quality control apparatus of the ER which is responsible for recognition and degradation of misfolded proteins. The investigator has also found that the proteasome plays a key role in the degradation of a1ATZ. More recent studies have shown that the classical autophagic response also plays a role in response to, and degradation of a1-ATZ. In addition, the investigator has evidence which suggests that exogenous chemical chaperones can at least partially reverse the folding defect of a1-ATZ and at least on of these, 4-phenylbutyric acid, is an excellent candidate for chemoprophylaxis of both liver and lung disease in a1-AT-deficiency. In addition, the investigator has also observed that several inhibitors of carbohydrate processing, castanospermine and kifunensine, also mediate increased secretion of a1ATZ. Thus, in the renewal application, the investigator proposes to focus on the effects of chemical chaperones and inhibitors of carbohydrate processing on mutant a1-AT-deficient patients. The investigator also plans to continue the studies of proteolytic mechanisms which determine the fate of a1-ATZ in the ER and of specific, presumably protective, signal transduction pathways that are activated by the retention of a1-ATZ in the ER. Lastly, the investigator proposes to determine whether there are tissue-specific differences in ER retention of a1-ATZ and the autophagic response in the lung and liver of PiZ mouse in vivo during homeostasis and inflammation.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL037784-15
Application #
6363503
Study Section
Pathobiochemistry Study Section (PBC)
Program Officer
Croxton, Thomas
Project Start
1986-09-01
Project End
2001-05-31
Budget Start
2001-03-01
Budget End
2001-05-31
Support Year
15
Fiscal Year
2001
Total Cost
$70,334
Indirect Cost
Name
Washington University
Department
Pediatrics
Type
Schools of Medicine
DUNS #
062761671
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Maurice, Nicholas; Perlmutter, David H (2012) Novel treatment strategies for liver disease due to ?1-antitrypsin deficiency. Clin Transl Sci 5:289-94
Hidvegi, Tunda; Ewing, Michael; Hale, Pamela et al. (2010) An autophagy-enhancing drug promotes degradation of mutant alpha1-antitrypsin Z and reduces hepatic fibrosis. Science 329:229-32
Perlmutter, D H (2009) Autophagic disposal of the aggregation-prone protein that causes liver inflammation and carcinogenesis in alpha-1-antitrypsin deficiency. Cell Death Differ 16:39-45
Scott, Craig M; Kruse, Kristina B; Schmidt, Bela Z et al. (2007) ADD66, a gene involved in the endoplasmic reticulum-associated degradation of alpha-1-antitrypsin-Z in yeast, facilitates proteasome activity and assembly. Mol Biol Cell 18:3776-87
Hidvegi, Tunda; Mirnics, Karoly; Hale, Pamela et al. (2007) Regulator of G Signaling 16 is a marker for the distinct endoplasmic reticulum stress state associated with aggregated mutant alpha1-antitrypsin Z in the classical form of alpha1-antitrypsin deficiency. J Biol Chem 282:27769-80
Perlmutter, David H (2006) The role of autophagy in alpha-1-antitrypsin deficiency: a specific cellular response in genetic diseases associated with aggregation-prone proteins. Autophagy 2:258-63
Perlmutter, David H (2006) Pathogenesis of chronic liver injury and hepatocellular carcinoma in alpha-1-antitrypsin deficiency. Pediatr Res 60:233-8
Kamimoto, Takahiro; Shoji, Shisako; Hidvegi, Tunda et al. (2006) Intracellular inclusions containing mutant alpha1-antitrypsin Z are propagated in the absence of autophagic activity. J Biol Chem 281:4467-76
Rudnick, David A; Perlmutter, David H (2005) Alpha-1-antitrypsin deficiency: a new paradigm for hepatocellular carcinoma in genetic liver disease. Hepatology 42:514-21
Hidvegi, Tunda; Schmidt, Bela Z; Hale, Pamela et al. (2005) Accumulation of mutant alpha1-antitrypsin Z in the endoplasmic reticulum activates caspases-4 and -12, NFkappaB, and BAP31 but not the unfolded protein response. J Biol Chem 280:39002-15

Showing the most recent 10 out of 55 publications